Peer-influenced content. Sources you trust. No registration required. This is HCN.
MedCentral
“Biomarkers have moved in a healthy direction through the intervention, yet clinical responses did not see a statistically significant benefit during the duration of the trial.” — Alzheimer’s Association
Endocrinology, Diabetes, Metabolism December 2nd 2025
Medical News Today (MNT)
The results underscore a clear message: timing and patient selection are key — and early diagnosis and intervention make the biggest difference.
Geriatrics November 3rd 2025
MDLinx
For the first time, researchers found that empagliflozin, an established diabetes and heart medication, reduced markers of brain injury while restoring blood flow in critical brain regions.
Endocrinology, Diabetes, Metabolism November 3rd 2025
News Medical
Patients, with or without anemia, should be screened for elevated homocysteine or B12 deficiency because that may be one of the reversible factors in their cognitive decline.
Cardiology October 21st 2025
POINTER and FINGER are the first large-scale randomized trials to test multi-domain lifestyle interventions—like exercise, diet, cognitive training, and social engagement.
Family Medicine/General Practice October 9th 2025
The findings stress the importance of diagnosis timing in neurodegenerative risk modeling and suggest that both early-life exposures and recent comorbidities contribute to disease vulnerability.
Endocrinology, Diabetes, Metabolism October 1st 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS